The British Journal of Psychiatry (2008) 193: 93-95. doi: 10.1192/bjp.bp.108.051268
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Morriss, R.
Right arrow Articles by Benjamin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morriss, R.
Right arrow Articles by Benjamin, B.

EDITORIALS

Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease

Richard Morriss, MB ChB, MMedSci, MD, FRCPsych

University of Nottingham and Nottinghamshire Healthcare NHS Trust, Nottingham

Benson Benjamin, MD BS

Nottinghamshire Healthcare NHS Trust, Nottingham, UK

Correspondence: Professor Richard Morriss, University of Nottingham Division of Psychiatry, South Block, A Floor, Queens’ Medical Centre, Nottingham NG7 2UH, UK. Email: richard.morriss{at}nottingham.ac.uk

Declaration of interest

R.M. has received honoraria from various pharmaceutical companies for non-promotional lectures and consultancy work. He was also part of the National Institute for Health and Clinical Excellence (NICE) guideline group for bipolar disorder.

Richard Morriss (pictured) is Professor of Psychiatry and Community Mental Health at the University of Nottingham. Benson Benjamin is a trainee psychiatrist in Nottingham.

The National Strategic Framework for Renal Services introduced the routine reporting of estimated glomerular filtration rates (eGFR) on serum urea and electrolyte tests. Estimated glomerular filtration rates might reduce renal failure induced by lithium and cardiovascular mortality but there are many false positives. We propose how eGFR might be used in lithium monitoring.




This article has been cited by other articles:


Home page
 BMJHome page
M. Kripalani, J. Shawcross, J. Reilly, and J. Main
Lithium and chronic kidney disease
BMJ, July 3, 2009; 339(jul03_1): b2452 - b2452.
[Full Text]

Home page
 J PsychopharmacolHome page
G. Goodwin and Consensus Group of the British Association for Psy
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology
J Psychopharmacol, June 1, 2009; 23(4): 346 - 388.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
V. S. Gould, M. Hashmi, N. Amin, and A. Doshi
Increasing awareness of eGFR monitoring
The British Journal of Psychiatry, February 1, 2009; 194(2): 191 - 191.
[Full Text] [PDF]

Home page
 JWatch PsychiatryHome page
Reviews of Note
Journal Watch Psychiatry, October 20, 2008; 2008(1020): 3 - 3.
[Full Text]

eLetters:

Read all eLetters

EGFR and renal failure associated with long term lithium use.
James Shawcross, et al.
BJP Online, 3 Sep 2008 [Full text]